Dual-specificity phosphatase 3 deletion promotes obesity, non-alcoholic steatohepatitis and hepatocellular carcinoma.
Jacques S, Arjomand A, Perée H, Collins P, Mayer A, Lavergne A, Wéry M, Mni M, Hego A, Thuillier V, Becker G, Bahri MA, Plenevaux A, Di Valentin E, Oury C, Moutschen M, Delvenne P, Paquot N, Rahmouni S.
Jacques S, et al. Among authors: moutschen m.
Sci Rep. 2021 Mar 12;11(1):5817. doi: 10.1038/s41598-021-85089-6.
Sci Rep. 2021.
PMID: 33712680
Free PMC article.